Journey Medical Q4 2023 Adj EPS $0.03 Beats $(0.08) Estimate, Sales $15.257M Beat $15.061M Estimate
Journey Medical Q4 2023 Adj EPS $0.03 Beats $(0.08) Estimate, Sales $15.257M Beat $15.061M Estimate
Journey Medical 2023年第四季度調整後每股收益爲0.03美元，超過預期（0.08美元），銷售額爲1,5257萬美元，超過150.61萬美元的預期
Journey Medical (NASDAQ:DERM) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 137.5 percent. The company reported quarterly sales of $15.257 million which beat the analyst consensus estimate of $15.061 million by 1.30 percent. This is a 4.44 percent decrease over sales of $15.966 million the same period last year.
Journey Medical（納斯達克股票代碼：DERM）公佈的季度收益爲每股0.03美元，比分析師普遍預期的0.08美元（0.08美元）高出137.5％。該公司公佈的季度銷售額爲1525.7萬美元，比分析師普遍預期的1,506.1萬美元高出1.30％。這比去年同期的1596.6萬美元的銷售額下降了4.44％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間